CMS: GENERICS HELP KEEP PART D COSTS DOWN

APRIL 01, 2006

Generic medicines will play a key role in the government's efforts to hold down Medicare prescription drug benefit costs, according to Centers for Medicare & Medicaid Services (CMS) Administrator Mark McClellan, MD, PhD.

Dr. McClellan released new CMS data to Congress suggesting that the cost of Medicare Part D is already significantly lower than originally projected. According to those figures, the net cost to the government for drug coverage in 2006 is expected to be $30.5 billion, down from previous estimates of $38.1 billion. Additionally, premiums for the average individual will be about a third less than previously estimated, at $25 per month. Over 10 years, the program is now expected to weigh in at $70 billion less than originally projected.




SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

Pharmacy Times Strategic Alliance
 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.